Medtech veteran Christopher Jones, the CEO of medical device company GlySure, tells MassDevice.com about his experiences in the U.S. and across the pond, with some words of guidance for companies pursuing a Europe-1st strategy.
GlySure CEO Christopher Jones has a career spanning more than 2 decades and 2 continents, during which he's seen the medtech regulatory pendulum swing from the Europe to the U.S. and back.
In an exclusive interview with MassDevice.com, Jones told us about being an American executive in the U.K., changing regulatory timelines and challenges to look for with a Europe-1st strategy.
EnteroMedics CEO Mark Knudson and CFO Greg Lea tell MassDevice.com about the company's Maestro weight loss pacemaker and how a twist on neuromodulation may help patients eat less and feel full without anatomy-altering surgery.
The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells MassDevice.com.
MassDevice discusses medical devices for mobile phones and the future of networked patient care with Dr. Leslie Saxon, cardiology chief at the University of Southern California.
As cardiology chief of the Keck School of Medicine at the University of Southern California, Dr. Leslie Saxon is spearheading a successful mobile health innovation center called the Center for Body Computing. Founded in 2010, the coalition works with engineers, device companies and thought leaders to develop mobile health software and apps.
Saxon's ultimate goal is to create a single platform that is the "epicenter of wireless health." The CBC...
OptiMedica CEO Mark Forchette tells MassDevice why femtosecond laser technology is changing the game in cataract surgery and how the promise of the technology lured him away from steady path at the largest ophthalmology company.
Updated: July 18, 2012 11:30 a.m.
OptiMedica Corp. is making waves and challenging the leaders in global eye care with its Catalys Precision Laser system for cataract surgery and CEO Mark Forchette isn't shy about extolling his company's potential.
The Catalys system, which won FDA clearance in December 2011 and CE Mark approval in the European Union in August 2011, performs key incisions during cataract...
Veniti founder, president & CEO Sean Morris tells MassDevice how he intends to conquer the venous disease space with a 3-pronged approach partially inspired by Julius Caesar.